Hsiu-wei Lin, MD in Walnut Creek, CA - Medicare Internal Medicine

Hsiu-wei Lin, MD is a medicare enrolled "Internal Medicine - Critical Care Medicine" physician in Walnut Creek, California. His current practice location is 1425 S Main St, Walnut Creek, California. You can reach out to his office (for appointments etc.) via phone at (925) 295-4000.

Hsiu-wei Lin is licensed to practice in California (license number A44619) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1427136514.

Contact Information

	Hsiu-wei Lin, MD
	1425 S Main St, Walnut Creek, CA 94596-5318
	(925) 295-4000
	Not Available

Physician's Profile

Full Name	Hsiu-wei Lin
Gender	Male
Speciality	Internal Medicine - Critical Care Medicine
Location	1425 S Main St, Walnut Creek, California
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1427136514
Provider Enumeration Date: 11/02/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 2062691314
Enrollment ID: I20110119000904

Medical Identifiers

Medical identifiers for Hsiu-wei Lin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427136514	NPI	-	NPPES
00A446190	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0200X	Internal Medicine - Critical Care Medicine	A44619 (California)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hsiu-wei Lin allows following entities to bill medicare on his behalf.

Entity Name	Permanente Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710

News Archive

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.

FRC refutes RCOG claims on fetal pain

The Family Research Council today released a new report that refutes claims made recently by the Royal College of Obstetricians and Gynaecologists' (RCOG) that a fetus is not able to feel pain before 24 weeks of development. RCOG's study is being used to uphold Britain's current legalization of abortions up to 24 weeks.

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Because of the very high costs in developing drugs for rare genetic diseases, and the low return on investment, the pharmaceutical industry has rarely developed specific treatments for many of these diseases.

Study finds new generation of drug-coated stent benefits heart patients

A two-year study comparing a new generation drug-coated stent, XIENCE, with a currently used drug eluting stent, TAXUS, has found that the XIENCE stent had superior benefits in more than 1,000 patients and is better at keeping the arteries of chest pain patients clear of blood clots.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hsiu-wei Lin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Hsiu-wei Lin, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3429 Ph: (510) 625-6262	Hsiu-wei Lin, MD 1425 S Main St, Walnut Creek, CA 94596-5318 Ph: (925) 295-4000

News Archive

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

FRC refutes RCOG claims on fetal pain

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Study finds new generation of drug-coated stent benefits heart patients

Internal Medicine Doctors in Walnut Creek, CA

Dr. Joseph Patrick Henry, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396
Mr. Ramin Khashayar, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1399 Ygnacio Valley Rd, Ste 14, Walnut Creek, CA 94598 Phone: 925-939-3050 Fax: 925-939-3057
Dr. Hennessey Tseng, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd, Suite 220b, Walnut Creek, CA 94597 Phone: 925-937-1770 Fax: 925-937-0630
Dr. Ali-reza Barmaki, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396
Dr. Cynthia M. Mullen, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-322-2372 Fax: 925-322-6720
Mr. David Nathanson, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000
Mark D Nathan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 La Casa Via, #140, Walnut Creek, CA 94598 Phone: 925-274-2860 Fax: 925-932-4527

Hsiu-wei Lin, MD - Medicare Internal Medicine in Walnut Creek, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

FRC refutes RCOG claims on fetal pain

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Study finds new generation of drug-coated stent benefits heart patients

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

FRC refutes RCOG claims on fetal pain

European Rare Diseases Therapeutic Initiative could provide an important new mechanism for developing new drugs

Study finds new generation of drug-coated stent benefits heart patients

Internal Medicine Doctors in Walnut Creek, CA